Q BioMed Inc. (QBIO)

Q BioMed Ratios and Metrics

Market cap in millions USD. Fiscal year is December - November.

Year	Current	2022	2021	2020	2019	2018
Market Capitalization	0	1	12	24	24	27
Market Cap Growth	-	-94.09%	-50.32%	1.30%	-10.15%	-43.01%
Enterprise Value	-	5	15	24	28	27
PE Ratio	0.01	-1.00	-1.38	-1.77	-2.05	-2.89
PS Ratio	0.97	2.52	61.91	812.55	-	-
PB Ratio	0	-0.16	-2.58	-22.67	-4.77	-253.32
P/FCF Ratio	0.01	0.37	-2.81	-3.91	-5.86	-3.85
P/OCF Ratio	0.01	0.37	-2.81	-3.91	-5.86	-4.15
EV/Sales Ratio	-	16.80	75.76	809.72	-	-
EV/EBITDA Ratio	-	-18.92	-2.02	-1.85	-3.46	-2.99
EV/EBIT Ratio	-	-15.79	-2.01	-1.85	-3.44	-
EV/FCF Ratio	-	2.46	-3.44	-3.90	-6.72	-3.88
Debt / Equity Ratio	0	-0.89	-0.65	-0.09	-0.73	-27.18
Debt / EBITDA Ratio	-	-16.28	-0.42	-0.01	-0.46	-0.32
Debt / FCF Ratio	-	2.12	-0.71	-0.01	-0.90	-0.41
Quick Ratio	0	0.01	0.08	0.10	0.03	6.25
Current Ratio	0	0.01	0.08	0.13	0.04	6.28
Asset Turnover	0.00	0.08	0.24	0.05	0	0
Interest Coverage	0	-2.49	-14.58	-44.38	-5.49	-55.64
Return on Equity (ROE)	-	15.51%	186.70%	1282.07%	232.69%	8768.52%
Return on Assets (ROA)	-	-20.37%	-1080.63%	-2211.51%	-1833.54%	-289.99%
Return on Capital (ROIC)	-	679.02%	452.64%	1336.87%	592.00%	-325.91%
Earnings Yield	10172.71%	-100.00%	-72.24%	-56.56%	-48.79%	-34.61%
FCF Yield	17432.32%	271.10%	-35.53%	-25.57%	-17.06%	-25.95%
Buyback Yield / Dilution	-67.13%	-20.84%	-47.34%	-9.50%	-31.23%
Total Shareholder Return	-67.13%	-20.84%	-47.34%	-9.50%	-31.23%

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.